1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Single-Cell Characterization of Hepatic CD8 + T Cells in a Murine Model of Primary Biliary Cholangitis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Primary biliary cholangitis (PBC), an organ-specific autoimmune disease, is characterized by injury to small bile ducts, inflammatory cell infiltrates within the liver, progressive cholestasis, and in some cases, cirrhosis with unclear pathogenesis. We aimed to clarify the importance role of hepatic immunce cells in the pathogenesis of human and experimental PBC.The dominant-negative TGFβ receptor type II transgenic (dnTGFβRII) mice, a well-studied and established murine model of PBC were used to identify changes of immune cells, especially the pathogenic CD8 + T cells. The high-throughput single-cell RNA sequencing technology were applied and found functional heterogeneity among the hepatic CD8 + T cells subsets in dnTGFβRII mice. CD8 + T cells were confirmed the key cells leading to the pathogenesis of PBC in dnTGFβRII mice, and identified the terminally differentiated CD8αα T cells and CD8αβ T cell subsets in the liver of dnTGFβRII mice. While terminally differentiated CD8αα T cells have higher cytokine production ability and cytotoxicity, the terminally differentiated CD8αβ T cells retain their proliferative profile. Our work suggests that there are developmental and differentiated trajectories of pathogenic CD8 + T cell subsets in the pathogenesis of PBC. A further clarification of their roles would be helpful to our understanding of the pathogenesis of PBC and may potentially lead to identifying novel therapeutic modalities.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites.

          Tissue-resident memory T cells (TRMs) in mice mediate optimal protective immunity to infection and vaccination, while in humans, the existence and properties of TRMs remain unclear. Here, we use a unique human tissue resource to determine whether human tissue memory T cells constitute a distinct subset in diverse mucosal and lymphoid tissues. We identify a core transcriptional profile within the CD69+ subset of memory CD4+ and CD8+ T cells in lung and spleen that is distinct from that of CD69- TEM cells in tissues and circulation and defines human TRMs based on homology to the transcriptional profile of mouse CD8+ TRMs. Human TRMs in diverse sites exhibit increased expression of adhesion and inhibitory molecules, produce both pro-inflammatory and regulatory cytokines, and have reduced turnover compared with circulating TEM, suggesting unique adaptations for in situ immunity. Together, our results provide a unifying signature for human TRM and a blueprint for designing tissue-targeted immunotherapies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.

            Interleukin-2 (IL-2) is a pleiotropic cytokine produced after antigen activation that plays pivotal roles in the immune response. Discovered as a T cell growth factor, IL-2 additionally promotes CD8(+) T cell and natural killer cell cytolytic activity and modulates T cell differentiation programs in response to antigen, promoting naïve CD4(+) T cell differentiation into T helper 1 (Th1) and T helper 2 (Th2) cells while inhibiting T helper 17 (Th17) and T follicular helper (Tfh) cell differentiation. Moreover, IL-2 is essential for the development and maintenance of T regulatory cells and for activation-induced cell death, thereby mediating tolerance and limiting inappropriate immune reactions. In this review, we focus on the molecular mechanisms and complex cellular actions of IL-2, its cooperative and opposing effects with other cytokines, and how both promoting and blocking the actions of IL-2 are being utilized in clinical medicine. Copyright © 2013 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

                Bookmark

                Author and article information

                Contributors
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                20 April 2022
                2022
                : 13
                : 860311
                Affiliations
                [1] 1Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science and Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education , Beijing, China
                [2] 2School of Medicine, South China University of Technology , Guangzhou, China
                [3] 3Medical Research Center, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences , Guangzhou, China
                [4] 4Department of Oncology of the First Affiliated Hospital, Chinese Academy of Sciences Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei, China
                [5] 5Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine , Davis, CA, United States
                Author notes

                Edited by: Ke Rui, Affiliated Hospital of Jiangsu University, China

                Reviewed by: Pietro Invernizzi, University of Milano-Bicocca, Italy; Jue Ling, Nantong University, China

                *Correspondence: Zhi-Bin Zhao, zzbin@ 123456mail.ustc.edu.cn ; Zhe-Xiong Lian, zxlian1@ 123456ustc.edu.cn ; Xiaofeng Zeng, zengxfpumc@ 123456163.com

                †These authors have contributed equally to this work

                This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology

                Article
                10.3389/fimmu.2022.860311
                9065443
                35514982
                54e8797a-4ad1-487a-8c2c-9f7508852b54
                Copyright © 2022 Han, Bian, Yang, Wang, Li, Yang, Ansari, Gershwin, Zeng, Lian and Zhao

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 22 January 2022
                : 22 March 2022
                Page count
                Figures: 6, Tables: 0, Equations: 0, References: 32, Pages: 13, Words: 6093
                Funding
                Funded by: National Natural Science Foundation of China , doi 10.13039/501100001809;
                Award ID: 82120108013, 81901652, 81801607
                Categories
                Immunology
                Original Research

                Immunology
                primary biliary cholangitis,cd8+ t cells,single-cell sequencing,tcr repertoire,liver
                Immunology
                primary biliary cholangitis, cd8+ t cells, single-cell sequencing, tcr repertoire, liver

                Comments

                Comment on this article